Lifers with Christina Farr

Luba Greenwood and Ash Zenooz interview Jonathan Bush. Jonathan is the CEO of a16z-backed Zus Health, Executive Chairman of Firefly Health and a co-founder of Athena Health. They discuss how the real opportunity lies in using AI to tackle healthcare's mundane "shit work" - like automating administrative tasks and streamlining data entry - rather than pursuing moonshot goals like curing cancer.  —...

In this episode of Second Opinion, Christina Farr is joined by John Zutter, CEO of Lantern, and Matt Harmon,  a long time benefits executive who's worked at fortune 100 companies to discuss the rising costs of healthcare, focusing on how large employers are addressing the financial impacts of treatments like cell and gene therapies and medications such as GLP-1s while exploring the challenges, str...

In this episode of Second Opinion, Christina Farr and Luba Greenwood chat with Mike Desjadon, CEO of Anomaly Health, about the state of American healthcare heading into 2025. Mike breaks down how health insurance companies actually make money and explains why we spend $500 billion just processing medical bills. They discuss the security concerns around J.P. Morgan Healthcare Conference after a tum...

Ash Zenooz and Luba Greenwood interview Andrea Ippolito about her extensive career in healthcare spanning academia, government, and the private sector, as well as her current role as founder and CEO of SimpliFed. They discuss the intricacies of government roles, the importance of women's health, and the evolving landscape of maternal health care and entrepreneurship. For full show notes, visit: ht...

Luba Greenwood and Ash Zenooz discuss the evolving biotech landscape, the impact of AI on drug discovery, the importance of using real-world evidence in drug development, and personal motivations for continuing efforts in the biotech field. For full show notes, visit: https://highlightai.com/share/f4d42739-65df-42d9-a6b4-6c1327705d7a  — 📰Be notified early when Turpentine drops new publication: ht...

Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Zeke Emanuel, a prominent oncologist, bioethicist, and influential voice in healthcare to discuss the impact of GLP-1 drugs, healthcare affordability, Trump's appointments, and AI in medicine. The second half of the episode was recorded a week after Trump's election victory. For full show notes, visit: https://highlightai.com/share/dd714...

Christina Farr and Ash Zenooz discuss the recent departures of prominent female CEOs from major healthcare companies and explore why progress in female leadership representation has been challenging in the healthcare industry. For full show notes, visit: https://highlightai.com/share/f0e550de-d7d5-49bd-96ea-700dde222ccc  — 📰 Be notified early when Turpentine drops new publication: https://www.tur...

In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood interview Rob Perez, founder of Life Science Cares, about his work bridging the biotech industry with poverty alleviation efforts. For full show notes, visit: https://highlightai.com/share/f3eb77b0-b71c-40fe-817e-bd3c1b4dc5b4  — RECOMMENDED PODCAST: 🎙️ Unpack Pricing - Dive into the dark arts of SaaS pricing wi...

Dr. Lloyd Minor, Dean of Stanford School of Medicine joins Christina Farr, Ash Zenooz, and Luba Greenwood to discuss the various transformative advancements and challenges in healthcare, focusing on the equitable use of AI and technology to enhance patient care, improve medical training, and address labor shortages. They dive into AI’s role in imaging, pathology, and electronic health records, as...

In this episode of Second Opinion, Christina Farr, Ash Zenooz, and Luba Greenwood discuss the integration and evaluation of digital tools in healthcare with guest Caroline Pearson from the Peterson Health Technology Institute. They explore the challenges in demonstrating clinical effectiveness and affordability of digital health solutions, using diabetes management tools as a case example. They ad...

In this episode of Second Opinion, Christina Farr, Ash Zenooz, and Luba Greenwood discuss the evolving landscape of healthcare leadership with Oxeon CEO Sonia Millsom. They explore what makes a great healthcare CEO, covering current talent market trends, qualities of successful leaders, and the valuable roles of executive chairs in a company. Sonia offers invaluable insights into the art of relati...

In this episode of the Second Opinion Podcast, Christina Farr, Ash Zenooz, and Luba Greenwood engage in a candid conversation with Dr. Isaac (Zak) Kohane, a renowned AI expert and chair at Harvard Medical School's Department of Biomedical Informatics.  Zak expresses his optimism about AI in healthcare, sharing personal anecdotes to illustrate how tools like ChatGPT can enhance patient care by prov...

In this episode of Second Opinion, Christina Farr is joined by Carine Carmy, CEO of Origin to discuss the overlooked aspects of women's healthcare, a case for a physical clinic, and funding stigmatized fields within the complex healthcare landscape. Carine shares valuable insights on scaling the business, the importance of evidence-based care, and the future of pelvic health, including the potenti...

In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood dive into the intricacies of the behavioral health industry with Alex Katz, CEO of Two Chairs. They discuss the misconceptions and challenges within the mental health system, the importance of finding the right therapeutic fit, and the impact of venture capital in driving both quality and accessibility in menta...

In this episode of Second Opinion, Leslie Schrock, author of Bumpin' and Fertility Rules, joins Christina Farr, Ash Zenooz, and Luba Greenwood to discuss women's health, men's health, and fertility. They dive into why men need to be more involved in fertility and pregnancy conversations (it's not just a women's issue!). They address the gaps in women's health research, including the lack of unders...

In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood sit down with Owen Tripp, the CEO of Included Health. They discuss digital health models, the challenges and opportunities in selling directly to employers, growing digital health companies, and the potential return to a more personalized, concierge-style primary care model to actually make a difference in peop...

In this episode of Second Opinion, Meg FitzGerald, a nurse turned private equity investor, offers insights into how VCs and PEs are thinking of investing in healthcare and everything founders should know to raise from both. She discusses the slowdown in private equity deals due to high interest rates and market uncertainty, and highlights the merging of venture capital and private equity in health...

In this eye-opening episode, Christina Farr and Luba Greenwood dive deep into the challenges big tech faces in healthcare with serial entrepreneur and Cherish CEO Sumit Nagpal. Drawing from his experience founding five companies over the past 25 years and his time working with Steve Jobs at NeXT, Nagpal offers unique insights into why tech giants struggle to gain traction in the medical world. The...

In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Daphne Zohar, Founder and CEO of Seaport Therapeutics. They talk about the complexities of drug development, the investment in biotech via big tech VCs, and the future of mental health treatments. Daphne also shares her insights on biotech today, drug development misconceptions and complex regulat...

On the first episode of Second Opinion, Christina Farr, Ash Zenooz, and Luba Greenwood chat with Dr. Robin Berzin, the Founder & CEO of Parsley Health. Robin shares her journey from being a physician to founding Parsley Health, a digital health company that uses root cause medicine to drive powerful outcomes for patients with complex health needs. She also talks about how breakthroughs in data and...

Second Opinion doesn't hold back. Join Christina Farr, Ash Zenooz, Luba Greenwood, as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Episode 1 with Robin Berzin, CEO of Parsley Health, will be available starting on July 31, 2024. Subscribe to Second Opinion wherever you get your podca...